期刊文献+

玻璃体内注射曲安奈德联合玻璃体切割术治疗玻璃体积血 被引量:10

Clinical assessment of combination procedure of intravitreal triamcinolone injection and vitrectomy in patients with vitreous hemorrhage
下载PDF
导出
摘要 目的探讨玻璃体内注射曲安奈德(TA)联合玻璃体切割术治疗玻璃体积血的临床应用。方法对因玻璃体积血住院手术的患者192例进行回顾性分析,比较玻璃体内注射TA联合玻璃体切割术和单纯行玻璃体切割术治疗前和治疗后ld、10d、1个月、3个月时患者的最佳矫正视力、眼压、眼内炎症反应和眼底改变。结果TA注射组在1个月、3个月最佳矫正视力高于单纯手术组,术后眼内炎症反应较单纯手术组降低,差异有统计学意义。结论与单纯玻璃体切割术比较,玻璃体内注射TA联合玻璃体切割术治疗玻璃体积血能在短期内获得更高的最佳矫正视力,并减少眼内炎症反应。 Objective Many researches showed that triamcinolone acetonide(TA) can treat many ocular fundus diseases effectively,and thus is widely concerned. This investigation was to assess the efficiency and safety of intravitreal triamcinolone injection during vitrectomy in patients with vitreous hemorrhage. Methods 192 cases of vitreous hemorrhage received vitrectomy were retrospectively investigated in this study. Patients undergone vitrectomy combined with intravitreal triamcinolone injection was as group A, and the patients with simple vitrectomy was as group B. Best corrected visual acuity, intraocular pressure (IOP), inflammatory reaction,findings of lens and fundus were evaluated before surgery and 1 day, 10 days, 1 month,3 months after surgery and compared between group A and group B. Results There was no statistical difference in mean visual acuity in preoperation between two groups(t = 0. 165, P = 0. 820). The mean acuity in 1 month and 3 months after surgery in group A was significantly higher than that of group B(t = 15. 334,P 〈0. 001 ;t = 18. 518 ,P 〈0. 001 ). The grading and eye numbers of inflammatory reaction in group A was significantly decreased in comparison with group B (P 〈 0. 005 ). The complication of intravitreal triamcinolone injection + vitrectomy was elevation of intraocular pressure( over 21 mmHg) in 13( 13.5% ) of 96 eyes in group A and 11 ( 10. 2% ) of 108 eyes in group B(χ^2 = 0. 60,P = 0. 46). Conclusion Combination of intravitreal triamcinolone injection and vitrectomy is helpful for recovery of visual function in short-term and present slight inflammatory process.
出处 《眼科研究》 CSCD 北大核心 2007年第10期775-777,共3页 Chinese Ophthalmic Research
关键词 玻璃体切割术 曲安奈德 玻璃体积血 vitrectomy triamcinolone acetonid vitreous hemorrhage
  • 相关文献

参考文献10

  • 1Holz FG, Spaide RF. Medical retina : Intravitreal injection of triameinolone acetonide[ M ]. Heidelberg: Springer,2005. 143 - 164.
  • 2姜燕荣,王凯,黎晓新.曲安奈德玻璃体腔注射治疗视网膜静脉阻塞继发黄斑水肿的疗效观察[J].眼科研究,2006,24(6):639-642. 被引量:18
  • 3Ciardella AP, Klancnik J, Schiff W,et al. Intravitreal triamcinolone for the treatment of exudates: an optical coherence tomography study refractory diabetic macular oedema with hard[ J]. Br J Ophthalmol,2004,88: 1131 - 1136.
  • 4Hogan MJ, Kimura SJ, Thygeson P. Signs and symptoms of uveitis. l. Anterior uveitis[ J]. Am J Ophthalmol, 1959,47 (5) : 155 -170.
  • 5Edelman JL, Lutz D, Castro MR. Corticosteroids inhibit VEGF induced vascular leakage in a rabbit model of blood-retinal and blood-aqueous barrier breakdown[ J ]. Exp Eye Res ,2005,80: 249 - 258.
  • 6Tong JP, Dennis SC, Wai MC, et al. Effects of triamcinolone on the expression of VEGF and PEDF in human retinal pigment epithelial and human umbilical vein endothelial ceils [ J ]. Mol Vis, 2006, 12 : 1490 - 1495.
  • 7王树林,金学民.糖尿病鼠视网膜细胞间黏附分子-1的表达与血视网膜屏障破坏的关系及曲安奈德的治疗作用[J].中华眼底病杂志,2006,22(1):24-27. 被引量:8
  • 8Hui YN,Hu D. Prevention of experimental proliferative vitreoretinopathy with daunomycin and triamcinolone based on the time course of the disease[ J]. Graefe' s Arch Clin Exp Ophthalmol, 1999,237: 601 - 605.
  • 9Jonas JB, Hayler JK, Panda-Jonas S. lntravitreal injection of crystalline cortisone as adjunctive treatment of proliferative vitreoretinopathy [ J ]. Br J Ophthalmol,2000,84: 1064 - 1067.
  • 10Ozkiris A, Erkilic K. Complications of intravitreal injection of triamcinolone acetonide [ J ]. Can J Ophthalmol,2005,40: 63 - 68.

二级参考文献21

  • 1Joussen AM,Poulaki V,Le ML,et al.A central role for inflammation in the pathogenesis of diabetic retinopathy.FASEB J,2004,18:1450-1452.
  • 2Krohne TU,Fauser S,Kirchhof B,et al.Pathogenesis of diabetic macular oedema.Klin Monatsbl Augenheilkd,2003,220:521-525.
  • 3Sobel RA,Mithell ME,Foodren G.Intercellular adhesion molecule1(ICAM-1)in cellular immune reactions in the human central nervous system.Am J Pathol,1990,136:1309.
  • 4Xu QW,Qaum T,Adamis AP.Sensitive blood-retinal barrier breakdown quantitation using Evans blue.Invest Ophthalmol Vis Sci,2001,42:789-794.
  • 5Jonas JB.Intraocular availability of triamcinolone acetonide after intravitreal injection.Am J Ophthalmol,2004,137:560-562.
  • 6McCuen BW 2nd,Bessler M,Tano Y,et al.The lack of toxicity of intravitreally administered triamcinolone acetonide.Am J Ophthalmol,1981,91:785-788.
  • 7Jaissle GB,Szurman P,Bartz-Schmidt KU.Ocular side effects and complications of intravitreal triamcinolone acetonide injection.Ophthalmology,2004,101:121-128.
  • 8Jonas JB,Kreissig I,Sofker A,et al..Intravitreal injection of triamcinolone for diffuse diabetic macular edema.Arch Ophthalmol,2003,121:57-61.
  • 9Martidis A,Duker JS,Greenberg PB,et al.Intravitreal triamcinolone for refractory diabetic macular edema.Ophthalmology,2002,109:920-927.
  • 10Tranos PG,Wickremasinghe SS,Stangos NT,et al.Macular edema[J].Surv Ophthalmol,2004,49:470-490

共引文献24

同被引文献94

引证文献10

二级引证文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部